Respiratory manifestations of systemic lupus erythematosus: old and new concepts

被引:132
作者
Maria Pego-Reigosa, Jose [1 ]
Medeiros, Dina A. [2 ]
Isenberg, David A. [3 ]
机构
[1] Complexo Hosp Univ Vigo, Rheumatol Sect, Hosp Meixoeiro, Vigo 36200, Pontevedra, Spain
[2] Portuguese Inst Rheumatol, Dept Rheumatol, P-1050034 Lisbon, Portugal
[3] UCL, Div Med, Ctr Rheumatol Res, London W1T 4JF, England
来源
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY | 2009年 / 23卷 / 04期
关键词
systemic lupus erythematosus; lung; pleuropulmonary involvement; pulmonary vascular involvement; cancer; respiratory infection; pulmonary damage; respiratory mortality; PULMONARY ARTERIAL-HYPERTENSION; SHRINKING LUNG SYNDROME; ALVEOLAR HEMORRHAGE; CLINICAL-FEATURES; DISTRESS-SYNDROME; DAMAGE INDEX; RISK-FACTORS; DISEASE; THERAPY; PNEUMONITIS;
D O I
10.1016/j.berh.2009.01.002
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
The respiratory system is commonly involved ill systemic lupus erythematosus. Lung disorders are classified as primary (due to lupus) and secondary to other conditions. Pleuritis and pulmonary infections are the most prevalent respiratory manifestations of each type. Other infrequent manifestations include interstitial lung disease, acute lupus pneumonitis, diffuse alveolar haemorrhage, pulmonary arterial hypertension, acute reversible hypoxaemia and shrinking lung syndrome. Even when Current diagnostic tests contribute to all earlier diagnosis, the treatment of these manifestations is based on clinical experience and small series. Larger controlled trials of the different therapies in the treatment of those lung manifestations Of lupus are needed. Overall malignancy is little increased in lupus, but lung cancer and non-Hodgkin's lymphoma are among the most frequent types of cancer found in these patients. As Survival ill lupus patients has improved over recent decades, avoiding pulmonary damage emerges as all important objective. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:469 / 480
页数:12
相关论文
共 69 条
[1]
ACUTE REVERSIBLE HYPOXEMIA IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
ABRAMSON, SB ;
DOBRO, J ;
EBERLE, MA ;
BENTON, M ;
REIBMAN, J ;
EPSTEIN, H ;
RAPOPORT, DM ;
BELMONT, HM ;
GOLDRING, RM .
ANNALS OF INTERNAL MEDICINE, 1991, 114 (11) :941-947
[2]
PULMONARY-FUNCTION OF NONSMOKING PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
ANDONOPOULOS, AP ;
CONSTANTOPOULOS, SH ;
GALANOPOULOU, V ;
DROSOS, AA ;
ACRITIDIS, NC ;
MOUTSOPOULOS, HM .
CHEST, 1988, 94 (02) :312-315
[3]
ANDONOPOULOS AP, 1991, BRIT J RHEUMATOL, V30, P346
[4]
ASHERSON RA, 1990, J RHEUMATOL, V17, P1292
[5]
Sitaxsentan therapy for pulmonary arterial hypertension [J].
Barst, RJ ;
Langleben, D ;
Frost, A ;
Horn, EM ;
Oudiz, R ;
Shapiro, S ;
McLaughlin, V ;
Hill, N ;
Tapson, VF ;
Robbins, IM ;
Zwicke, D ;
Duncan, B ;
Dixon, RAF ;
Frumkin, LR .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 169 (04) :441-447
[6]
Begum S, 2002, CLIN EXP RHEUMATOL, V20, P549
[7]
UP-REGULATION OF ENDOTHELIAL-CELL ADHESION MOLECULES CHARACTERIZES DISEASE-ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS - THE SHWARTZMAN PHENOMENON REVISITED [J].
BELMONT, HM ;
BUYON, J ;
GIORNO, R ;
ABRAMSON, S .
ARTHRITIS AND RHEUMATISM, 1994, 37 (03) :376-383
[8]
The relationship between cancer and medication exposures in systemic lupus erythaematosus:: a case-cohort study [J].
Bernatsky, S. ;
Joseph, L. ;
Boivin, J-F ;
Gordon, C. ;
Urowitz, M. ;
Gladman, D. ;
Fortin, P. R. ;
Ginzler, E. ;
Bae, S-C ;
Barr, S. ;
Edworthy, S. ;
Isenberg, D. ;
Rahman, A. ;
Petri, M. ;
Alarcon, G. S. ;
Aranow, C. ;
Dooley, M-A ;
Rajan, R. ;
Senecal, J-L ;
Zummer, M. ;
Manzi, S. ;
Ramsey-Goldman, R. ;
Clarke, A. E. .
ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (01) :74-79
[9]
Mortality in systemic lupus erythematosus [J].
Bernatsky, S. ;
Boivin, J. -F. ;
Joseph, L. ;
Manzi, S. ;
Ginzler, E. ;
Gladman, D. D. ;
Urowitz, M. ;
Fortin, P. R. ;
Petri, M. ;
Barr, S. ;
Gordon, C. ;
Bae, S. -C. ;
Isenberg, D. ;
Zoma, A. ;
Aranow, C. ;
Dooley, M. -A. ;
Nived, O. ;
Sturfelt, G. ;
Steinsson, K. ;
Alarcon, G. ;
Senecal, J. -L. ;
Zummer, M. ;
Hanly, J. ;
Ensworth, S. ;
Pope, J. ;
Edworthy, S. ;
Rahman, A. ;
Sibley, J. ;
El-Gabalawy, H. ;
McCarthy, T. ;
Pierre, Y. St. ;
Clarke, A. ;
Ramsey-Goldman, R. .
ARTHRITIS AND RHEUMATISM, 2006, 54 (08) :2550-2557
[10]
Systemic lupus erythematosus in a multiethnic US Cohort LUMINA XLVIII:: factors predictive of pulmonary damage [J].
Bertoli, A. M. ;
Vila, L. M. ;
Apte, M. ;
Fessler, B. J. ;
Bastian, H. M. ;
Reveille, J. D. ;
Alarcon, G. S. .
LUPUS, 2007, 16 (06) :410-417